About - CRM197
PeliCRM197® - CRM197
Original Article Cross-Reacting Material 197, a Specific Inhibitor of HB-EGF, and Its Anticancer Effects
Addgene: pJL1-CRM197-4xDQNAT
Biochemical and biological characteristics of cross-reacting material 197 ( CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications - ScienceDirect
Effects of Conformational Changes in Peptide–CRM197 Conjugate Vaccines | Bioconjugate Chemistry
Effects of Conformational Changes in Peptide–CRM197 Conjugate Vaccines | Bioconjugate Chemistry
RCSB PDB - 4AE0: Crystal structure of diphtheria toxin mutant CRM197
Addgene: pTrc99S-ssDsbA-CRM197-4xDQNAT
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197 | PNAS
CRM197 protein - Scarab Genomics
Construction of pET32a-CRM197. The crm197 sequence was amplified using... | Download Scientific Diagram
BioTech | Free Full-Text | High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene’s mRNA Structure
Cross reacting material (CRM197) as a carrier protein for carbohydrate conjugate vaccines targeted at bacterial and fungal pathogens - ScienceDirect
BioTech | Free Full-Text | High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene’s mRNA Structure
Construction of pET32a-CRM197. The crm197 sequence was amplified using... | Download Scientific Diagram
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197 | PNAS
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. - Abstract - Europe PMC
Conjugate of structurally reassigned pneumococcal serotype 31 polysaccharide with CRM197 elicited potent immune response - ScienceDirect
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of g
BioTech | Free Full-Text | High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene’s mRNA Structure
RCSB PDB - 4AE1: Crystal structure of diphtheria toxin mutant CRM197 in complex with nicotinamide
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen | Scientific Reports
Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli | PLOS ONE
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites | Scientific Reports
Addgene: pJL1-CRM197-4xDQNAT
